Several studies have shown that the MIF genetic variants regulate the MIF serum levels in various diseases, such as; sarcoidosis, malaria, schistosomiasis, trypanosomiasis, leishmaniasis, rheumatoid arthritis, ulcerative colitis and atopy [12,14,21-28]. The gene discussed is MIF; the disease is leishmaniasis.